162 related articles for article (PubMed ID: 8820097)
1. Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells.
Musanti R; Giorgini L; Lovisolo PP; Pirillo A; Chiari A; Ghiselli G
J Lipid Res; 1996 Jan; 37(1):1-14. PubMed ID: 8820097
[TBL] [Abstract][Full Text] [Related]
2. Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures.
Brown A; Wiggins D; Gibbons GF
Biochim Biophys Acta; 1999 Sep; 1440(2-3):253-65. PubMed ID: 10521709
[TBL] [Abstract][Full Text] [Related]
3. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and secretions of apolipoprotein B-containing lipoprotein and bile acids in HepG2.
Azuma Y; Kawasaki T; Ohno K; Seto J; Yamada T; Yamasaki M; Nobuhara Y
Jpn J Pharmacol; 1999 Feb; 79(2):151-8. PubMed ID: 10202850
[TBL] [Abstract][Full Text] [Related]
4. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.
Avramoglu RK; Cianflone K; Sniderman AD
J Lipid Res; 1995 Dec; 36(12):2513-28. PubMed ID: 8847478
[TBL] [Abstract][Full Text] [Related]
5. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Wilcox LJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
Graham A; Wood JL; Russell LJ
Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
[TBL] [Abstract][Full Text] [Related]
7. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.
Burnett JR; Wilcox LJ; Huff MW
Clin Chim Acta; 1999 Aug; 286(1-2):231-42. PubMed ID: 10511295
[TBL] [Abstract][Full Text] [Related]
8. Correction of dyslipoproteinaemia of casein-fed rabbit by FCE 27677, a potent novel ACAT inhibitor.
Chiari A; Lovisolo P; Fogliatto G; Fancelli D; Ghiselli G
Pharmacol Res; 1996 Mar; 33(3):181-9. PubMed ID: 8880889
[TBL] [Abstract][Full Text] [Related]
9. FCE 27677: a novel inhibitor of acyl-CoA: cholesterol acyltransferase with potent oral hypolipidemic activity.
Chiari A; Lovisolo P; Radice A; Giorgini L; Fancelli D; Severino D; Ghiselli G
Pharmacol Res; 1995 Oct; 32(4):189-99. PubMed ID: 8866834
[TBL] [Abstract][Full Text] [Related]
10. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
[TBL] [Abstract][Full Text] [Related]
11. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys.
Carr TP; Hamilton RL; Rudel LL
J Lipid Res; 1995 Jan; 36(1):25-36. PubMed ID: 7706945
[TBL] [Abstract][Full Text] [Related]
12. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
J Lipid Res; 1999 Jul; 40(7):1317-27. PubMed ID: 10393217
[TBL] [Abstract][Full Text] [Related]
15. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
Cianflone KM; Yasruel Z; Rodriguez MA; Vas D; Sniderman AD
J Lipid Res; 1990 Nov; 31(11):2045-55. PubMed ID: 1964953
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
Huff MW; Telford DE; Barrett PH; Billheimer JT; Gillies PJ
Arterioscler Thromb; 1994 Sep; 14(9):1498-508. PubMed ID: 8068612
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester.
Wu X; Sakata N; Lui E; Ginsberg HN
J Biol Chem; 1994 Apr; 269(16):12375-82. PubMed ID: 8163541
[TBL] [Abstract][Full Text] [Related]
18. ACAT2 stimulates cholesteryl ester secretion in apoB-containing lipoproteins.
Temel RE; Hou L; Rudel LL; Shelness GS
J Lipid Res; 2007 Jul; 48(7):1618-27. PubMed ID: 17438337
[TBL] [Abstract][Full Text] [Related]
19. Influence of the acyl-CoA: cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue.
Kelley JL; Suenram CA; Rozek MM; Schaffer SA; Schwartz CJ
Biochim Biophys Acta; 1988 May; 960(1):83-90. PubMed ID: 3358947
[TBL] [Abstract][Full Text] [Related]
20. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages.
Graham A; Angell AD; Jepson CA; Yeaman SJ; Hassall DG
Atherosclerosis; 1996 Feb; 120(1-2):135-45. PubMed ID: 8645354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
